Form 4: VolitionRx GC Nicholas Plummer Reports Acquisition and Disposal of Common Stock

Nicholas Plummer, GC of VolitionRx, reports the acquisition of 12,483 restricted stock units (RSUs) and disposal of 177,628 common stock on March 1, 2025.

Summary

• On March 1, 2025, Nicholas Plummer, the General Counsel of VolitionRx Ltd, reported changes in beneficial ownership to the SEC.
• Plummer acquired 12,483 restricted stock units (RSUs) under the company's 2024 Stock Incentive Plan in lieu of cash compensation.
• These RSUs vest in three equal installments of 4,161 units on March 1, 2025, April 1, 2025, and May 1, 2025, with further time-based vesting on March 1, 2026, subject to continued service.
• Upon vesting and settlement, Plummer will receive common stock equal to the number of vested RSUs.
• Plummer also disposed of 177,628 common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing, reflecting routine transactions. The sentiment is neutral as it simply reports facts without expressing any opinion or forward-looking statements.

Positives

• The acquisition of RSUs by a key officer aligns their interests with the company's long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in the holdings of a key executive at VolitionRx.

Stakeholder Impact

• The acquisition of RSUs by a key officer aligns their interests with shareholders.

Key Dates

Keywords

VolitionRx, Nicholas Plummer, RSUs, Restricted Stock Units, Beneficial Ownership, SEC Form 4, VNRX, Stock Incentive Plan